Miles Capital’s Adeptus Health Inc ADPT Stock Holding History

Miles Capital’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,581	Closed	-$237K	–	230
2016 Q2	$237K	Buy	+4,581	New	+$275K	0.16%	157

Other funds holding ADPT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Axon Capital New York $73.7M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Miles Capital's ADPT Position: Q3 2016 in Review

Miles Capital sold out of Adeptus Health Inc (ADPT) in Q3 2016, closing a stake of 4,581 shares — an estimated $237K sold.

Miles Capital first reported a position in ADPT in Q2 2016 and held it in 1 quarter. The position peaked at $237K in Q2 2016. 134 funds tracked by Wall St. Rank hold ADPT as of Q3 2016.

Miles Capital reported no remaining Adeptus Health Inc position as of Q3 2016 after selling out during the quarter.
Miles Capital sold 4,581 Adeptus Health Inc shares in Q3 2016, an estimated $237K.
Miles Capital first reported a position in Adeptus Health Inc in Q2 2016 and held it in 1 quarter.
Miles Capital's Adeptus Health Inc position peaked at $237K in Q2 2016.
134 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q3 2016.

Based on Miles Capital's 13F filing for Q3 2016, filed 15 Nov 2016.